Literature DB >> 21069576

A new mutation in the menin gene causes the multiple endocrine neoplasia type 1 syndrome with adrenocortical carcinoma.

M Haase1, M Anlauf, M Schott, S Schinner, E Kaminsky, W A Scherbaum, Holger S Willenberg.   

Abstract

Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant tumor syndrome that may be caused by mutations in the MEN1 gene on 11q13. Loss of function of the tumor suppressor gene MEN1 leads to synchronous or metachronous appearance of neuroendocrine tumors arising from neuroendocrine cells of the parathyroid and pituitary glands, the duodenum and pancreatic islets, and other endocrine organs such as the adrenal cortex. We here present a patient with MEN1 who developed hyperparathyroidism, multiple well differentiated functionally inactive neuroendocrine tumors of the pancreas and an adrenal carcinoma. We describe a new mutation at codon 443 in the coding region of exon 9 in the MEN1 gene, where a cytosine residue was exchanged for adenosine (TCC > TAC) and, consequently, serine for tyrosine (p.Ser443Tyr; c.1328C > A). [corrected] Also, we provide clinical data that may add to the genotype-phenotype discussion. We conclude that the novel mutation in the MEN1 gene described herein was clinically relevant.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21069576     DOI: 10.1007/s12020-010-9424-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  20 in total

Review 1.  In search of tumor suppressing functions of menin.

Authors:  Yuqing Yang; Xianxin Hua
Journal:  Mol Cell Endocrinol       Date:  2007-01-11       Impact factor: 4.102

2.  MEN1 gene mutation analysis of sporadic adrenocortical lesions.

Authors:  B Görtz; J Roth; E J Speel; A Krähenmann; R R De Krijger; X Matias-Guiu; S Muletta-Feurer; K Rütmann; P Saremaslani; P U Heitz; P Komminoth
Journal:  Int J Cancer       Date:  1999-01-29       Impact factor: 7.396

3.  Differential expression of menin in various adrenal tumors. The role of menin in adrenal tumors.

Authors:  M M Bhuiyan; M Sato; K Murao; H Imachi; H Namihira; T Ishida; J Takahara; A Miyauchi
Journal:  Cancer       Date:  2001-09-15       Impact factor: 6.860

4.  Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1.

Authors:  J R Burgess; R A Harle; P Tucker; V Parameswaran; P Davies; T M Greenaway; J J Shepherd
Journal:  Arch Surg       Date:  1996-07

5.  Adrenal involvement in multiple endocrine neoplasia type 1.

Authors:  Peter Langer; Kenko Cupisti; Detlef K Bartsch; Christoph Nies; Peter E Goretzki; Matthias Rothmund; Hans D Röher
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

6.  Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.

Authors:  Gao Chen; Jingbo A; Min Wang; Steven Farley; Lung-Yi Lee; Lung-Ching Lee; Mark P Sawicki
Journal:  Mol Cancer Res       Date:  2008-12       Impact factor: 5.852

7.  Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states.

Authors:  Sunita K Agarwal; Carmen M Mateo; Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

8.  Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1.

Authors:  B Skogseid; C Larsson; P G Lindgren; E Kvanta; J Rastad; E Theodorsson; L Wide; E Wilander; K Oberg
Journal:  J Clin Endocrinol Metab       Date:  1992-07       Impact factor: 5.958

Review 9.  MEN1 gene and its mutations: basic and clinical implications.

Authors:  Toshihiko Tsukada; Yuko Nagamura; Naganari Ohkura
Journal:  Cancer Sci       Date:  2009-02       Impact factor: 6.716

Review 10.  Pathophysiological aspects of Wnt-signaling in endocrine disease.

Authors:  Sven Schinner; Holger S Willenberg; Matthias Schott; Werner A Scherbaum
Journal:  Eur J Endocrinol       Date:  2009-02-26       Impact factor: 6.664

View more
  6 in total

1.  The tumor suppressor protein menin inhibits NF-κB-mediated transactivation through recruitment of Sirt1 in hepatocellular carcinoma.

Authors:  Ding Gang; Hua Hongwei; Liu Hedai; Zhang Ming; Huang Qian; Liao Zhijun
Journal:  Mol Biol Rep       Date:  2012-12-06       Impact factor: 2.316

Review 2.  Association of adrenocortical carcinoma with familial cancer susceptibility syndromes.

Authors:  Tobias Else
Journal:  Mol Cell Endocrinol       Date:  2011-12-19       Impact factor: 4.102

Review 3.  What Did We Learn from the Molecular Biology of Adrenal Cortical Neoplasia? From Histopathology to Translational Genomics.

Authors:  C Christofer Juhlin; Ozgur Mete; Jérôme Bertherat; Thomas J Giordano; Gary D Hammer; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2021-02-03       Impact factor: 3.943

4.  Adrenocortical carcinoma in patients with MEN1: a kindred report and review of the literature.

Authors:  Weixi Wang; Rulai Han; Lei Ye; Jing Xie; Bei Tao; Fukang Sun; Ran Zhuo; Xi Chen; Xiaxing Deng; Cong Ye; Hongyan Zhao; Shu Wang
Journal:  Endocr Connect       Date:  2019-03-01       Impact factor: 3.335

Review 5.  Phenotypes Associated With MEN1 Syndrome: A Focus on Genotype-Phenotype Correlations.

Authors:  Chiara Mele; Monica Mencarelli; Marina Caputo; Stefania Mai; Loredana Pagano; Gianluca Aimaretti; Massimo Scacchi; Alberto Falchetti; Paolo Marzullo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-11-18       Impact factor: 5.555

6.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.